Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Liquid chromatography-tandem mass spectrometry assay for the quantification of free and total sialic acid in human cerebrospinal fluid

van der Ham, Maria ; de Koning, Tom J. LU ; Lefeber, Dirk ; Fleer, André ; Prinsen, Berthil H.C.M.T. and de Sain-van der Velden, Monique G.M. (2010) In Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 878(15-16). p.1098-1102
Abstract

Background: Analysis of sialic acid (SA) metabolites in cerebrospinal fluid (CSF) is important for clinical diagnosis. In the present study, a high-performance liquid chromatography-tandem mass spectrometry (HPLC/MS/MS) method for free sialic acid (FSA) and total sialic acid (TSA) in human CSF was validated. Methods: The method utilized a simple sample-preparation procedure of protein precipitation for FSA and acid hydrolysis for TSA. Negative electrospray ionisation was used to monitor the transitions m/z 308.2 → 87.0 (SA) and m/z 311.2 → 90.0 (13C3-SA). Conjugated sialic acid (CSA) was calculated by subtracting FSA from TSA. We established reference intervals for FSA, TSA and CSA in CSF in 217 control subjects.... (More)

Background: Analysis of sialic acid (SA) metabolites in cerebrospinal fluid (CSF) is important for clinical diagnosis. In the present study, a high-performance liquid chromatography-tandem mass spectrometry (HPLC/MS/MS) method for free sialic acid (FSA) and total sialic acid (TSA) in human CSF was validated. Methods: The method utilized a simple sample-preparation procedure of protein precipitation for FSA and acid hydrolysis for TSA. Negative electrospray ionisation was used to monitor the transitions m/z 308.2 → 87.0 (SA) and m/z 311.2 → 90.0 (13C3-SA). Conjugated sialic acid (CSA) was calculated by subtracting FSA from TSA. We established reference intervals for FSA, TSA and CSA in CSF in 217 control subjects. The method has been applied to patients' samples with known differences in SA metabolites like meningitis (n = 6), brain tumour (n = 2), leukaemia (n = 5), and Salla disease (n = 1). Results: Limit of detection (LOD) was 0.54 μM for FSA and 0.45 μM for TSA. Intra- and inter-assay variation for FSA (21.8 μM) were 4.8% (n = 10) and 10.4% (n = 40) respectively. Intra- and inter-assay variation for TSA (35.6 μM) were 9.7% (n = 10) and 12.8% (n = 40) respectively. Tested patients showed values of TSA above established reference value. Conclusion: The validated method allows sensitive and specific measurement of SA metabolites in CSF and can be applied for clinical diagnoses.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; and
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Cerebrospinal fluid, High-performance liquid chromatography-tandem mass spectrometry, Sialic acid
in
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
volume
878
issue
15-16
pages
5 pages
publisher
Elsevier
external identifiers
  • pmid:20362517
  • scopus:77950934803
ISSN
1570-0232
DOI
10.1016/j.jchromb.2010.03.020
language
English
LU publication?
no
id
a430d6a7-8fce-4dbc-b879-b8087b7e8f80
date added to LUP
2020-02-26 10:26:31
date last changed
2024-04-17 05:55:23
@article{a430d6a7-8fce-4dbc-b879-b8087b7e8f80,
  abstract     = {{<p>Background: Analysis of sialic acid (SA) metabolites in cerebrospinal fluid (CSF) is important for clinical diagnosis. In the present study, a high-performance liquid chromatography-tandem mass spectrometry (HPLC/MS/MS) method for free sialic acid (FSA) and total sialic acid (TSA) in human CSF was validated. Methods: The method utilized a simple sample-preparation procedure of protein precipitation for FSA and acid hydrolysis for TSA. Negative electrospray ionisation was used to monitor the transitions m/z 308.2 → 87.0 (SA) and m/z 311.2 → 90.0 (<sup>13</sup>C<sub>3</sub>-SA). Conjugated sialic acid (CSA) was calculated by subtracting FSA from TSA. We established reference intervals for FSA, TSA and CSA in CSF in 217 control subjects. The method has been applied to patients' samples with known differences in SA metabolites like meningitis (n = 6), brain tumour (n = 2), leukaemia (n = 5), and Salla disease (n = 1). Results: Limit of detection (LOD) was 0.54 μM for FSA and 0.45 μM for TSA. Intra- and inter-assay variation for FSA (21.8 μM) were 4.8% (n = 10) and 10.4% (n = 40) respectively. Intra- and inter-assay variation for TSA (35.6 μM) were 9.7% (n = 10) and 12.8% (n = 40) respectively. Tested patients showed values of TSA above established reference value. Conclusion: The validated method allows sensitive and specific measurement of SA metabolites in CSF and can be applied for clinical diagnoses.</p>}},
  author       = {{van der Ham, Maria and de Koning, Tom J. and Lefeber, Dirk and Fleer, André and Prinsen, Berthil H.C.M.T. and de Sain-van der Velden, Monique G.M.}},
  issn         = {{1570-0232}},
  keywords     = {{Cerebrospinal fluid; High-performance liquid chromatography-tandem mass spectrometry; Sialic acid}},
  language     = {{eng}},
  month        = {{05}},
  number       = {{15-16}},
  pages        = {{1098--1102}},
  publisher    = {{Elsevier}},
  series       = {{Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences}},
  title        = {{Liquid chromatography-tandem mass spectrometry assay for the quantification of free and total sialic acid in human cerebrospinal fluid}},
  url          = {{http://dx.doi.org/10.1016/j.jchromb.2010.03.020}},
  doi          = {{10.1016/j.jchromb.2010.03.020}},
  volume       = {{878}},
  year         = {{2010}},
}